omega-n-methylarginine has been researched along with mycophenolic acid in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (mycophenolic acid) | Trials (mycophenolic acid) | Recent Studies (post-2010) (mycophenolic acid) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 9,029 | 1,506 | 3,772 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | mycophenolic acid (IC50) |
|---|---|---|---|
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | 0.1496 | |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.014 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.014 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.014 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.014 | |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | 0.0772 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.011 | |
| Inosine-5'-monophosphate dehydrogenase | Cryptococcus neoformans var. neoformans JEC21 | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drakulic, D; Miljkovic, Dj; Samardzic, T; Stosic-Grujicic, S; Trajkovic, V | 1 |
| Booth, AD; Brown, J; Jayne, DR; Kharbanda, RK; Mackenzie, IS; McEniery, CM; Wilkinson, IB | 1 |
1 trial(s) available for omega-n-methylarginine and mycophenolic acid
| Article | Year |
|---|---|
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Autoimmune Diseases; C-Reactive Protein; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Infliximab; Interleukin-6; Male; Middle Aged; Mycophenolic Acid; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pilot Projects; Plethysmography; Prednisolone; Regional Blood Flow; Tumor Necrosis Factor-alpha; Vasculitis | 2004 |
1 other study(ies) available for omega-n-methylarginine and mycophenolic acid
| Article | Year |
|---|---|
Immunosuppressants leflunomide and mycophenolic acid inhibit fibroblast IL-6 production by distinct mechanisms.
Topics: Aniline Compounds; Animals; Cell Line; Cell Survival; Cells, Cultured; Coloring Agents; Crotonates; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Guanidines; Humans; Hydroxybutyrates; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Isoxazoles; Leflunomide; Macrophages; Mice; Mycophenolic Acid; Nitric Oxide Synthase; Nitriles; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Rolipram; Tetrazolium Salts; Thiazoles; Time Factors; Toluidines | 2002 |